Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.9199
At close: May 13 EDT
$0.9450
0.032.73%
Pre-Market: 9:13 AM EDT
Comments
Loading...
I-MAB Analyst Ratings and Price Targets | NASDAQ:IMAB | Benzinga
I-MAB has a consensus price target of $11.5 based on the ratings of 4 analysts. The high is $25 issued by Cantor Fitzgerald on September 5, 2023. The low is $4 issued by Needham on April 4, 2025. The 3 most-recent analyst ratings were released by Needham, HC Wainwright & Co., and HC Wainwright & Co. on April 4, 2025, April 4, 2025, and November 15, 2024, respectively. With an average price target of $6.33 between Needham, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 570.19% upside for I-MAB from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Needham
HC Wainwright & Co.
Piper Sandler
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for I-MAB
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/04/2025 | Buy Now | 323.28% | Needham | Gil Blum49% | $4 → $4 | Reiterates | Buy → Buy | Get Alert |
| 04/04/2025 | Buy Now | 640.74% | HC Wainwright & Co. | Andrew Fein55% | $8 → $7 | Maintains | Buy | Get Alert |
| 11/15/2024 | Buy Now | 746.56% | HC Wainwright & Co. | Andrew Fein55% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 09/17/2024 | Buy Now | 746.56% | HC Wainwright & Co. | Andrew Fein55% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/29/2024 | Buy Now | 746.56% | HC Wainwright & Co. | Andrew Fein55% | $8 → $8 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2024 | Buy Now | 534.92% | Needham | Gil Blum49% | $6 → $6 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2024 | Buy Now | 958.2% | Piper Sandler | Joseph Catanzaro42% | $15 → $10 | Maintains | Overweight | Get Alert |
| 03/18/2024 | Buy Now | 746.56% | HC Wainwright & Co. | Andrew Fein55% | $18 → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2024 | Buy Now | 534.92% | Needham | Gil Blum49% | $8 → $6 | Maintains | Buy | Get Alert |
| 02/08/2024 | Buy Now | 746.56% | Needham | Gil Blum49% | $23 → $8 | Maintains | Buy | Get Alert |
| 09/25/2023 | Buy Now | 2333.86% | Needham | Gil Blum49% | $24 → $23 | Maintains | Buy | Get Alert |
| 09/05/2023 | Buy Now | 2545.5% | Cantor Fitzgerald | Louise Chen53% | → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 08/18/2023 | Buy Now | 2545.5% | Cantor Fitzgerald | Louise Chen53% | → $25 | Reiterates | Overweight → Overweight | Get Alert |
| 08/18/2023 | Buy Now | 1804.76% | HC Wainwright & Co. | Andrew Fein55% | $25 → $18 | Maintains | Buy | Get Alert |
| 08/18/2023 | Buy Now | 2439.68% | Needham | Gil Blum49% | → $24 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | Buy Now | 2439.68% | Needham | Gil Blum49% | → $24 | Reiterates | Buy → Buy | Get Alert |
| 04/19/2023 | Buy Now | 2439.68% | Needham | Gil Blum49% | → $24 | Reiterates | → Buy | Get Alert |
| 04/03/2023 | Buy Now | 2439.68% | Needham | Gil Blum49% | $33 → $24 | Maintains | Buy | Get Alert |
| 04/03/2023 | Buy Now | 2545.5% | Piper Sandler | Joseph Catanzaro42% | $30 → $25 | Maintains | Overweight | Get Alert |
| 04/03/2023 | Buy Now | 2545.5% | HC Wainwright & Co. | Andrew Fein55% | $45 → $25 | Maintains | Buy | Get Alert |
| 08/31/2022 | Buy Now | 4661.9% | HC Wainwright & Co. | Andrew Fein55% | $70 → $45 | Maintains | Buy | Get Alert |
| 08/31/2022 | Buy Now | 3392.06% | Needham | Gil Blum49% | $41 → $33 | Maintains | Buy | Get Alert |
| 08/30/2022 | Buy Now | 3074.6% | Piper Sandler | Joseph Catanzaro42% | $35 → $30 | Maintains | Overweight | Get Alert |
| 08/17/2022 | Buy Now | 4238.62% | Needham | Gil Blum49% | $72 → $41 | Maintains | Buy | Get Alert |
| 05/31/2022 | Buy Now | 7307.41% | HC Wainwright & Co. | Andrew Fein55% | $80 → $70 | Maintains | Buy | Get Alert |
| 05/31/2022 | Buy Now | 7519.05% | Needham | Gil Blum49% | $85 → $72 | Maintains | Buy | Get Alert |
FAQ
What is the target price for I-MAB (IMAB) stock?
The latest price target for I-MAB (NASDAQ:IMAB) was reported by Needham on April 4, 2025. The analyst firm set a price target for $4.00 expecting IMAB to rise to within 12 months (a possible 323.28% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for I-MAB (IMAB)?
The latest analyst rating for I-MAB (NASDAQ:IMAB) was provided by Needham, and I-MAB reiterated their buy rating.
When was the last upgrade for I-MAB (IMAB)?
There is no last upgrade for I-MAB
When was the last downgrade for I-MAB (IMAB)?
There is no last downgrade for I-MAB.
When is the next analyst rating going to be posted or updated for I-MAB (IMAB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of I-MAB, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for I-MAB was filed on April 4, 2025 so you should expect the next rating to be made available sometime around April 4, 2026.
Is the Analyst Rating I-MAB (IMAB) correct?
While ratings are subjective and will change, the latest I-MAB (IMAB) rating was a reiterated with a price target of $4.00 to $4.00. The current price I-MAB (IMAB) is trading at is $0.95, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
